Search PubMed⌕ Search

Biomedical subjects

F Haschke

Publications and source records attributed to F Haschke.

At least 55 records · Page 3Linked to original sources
PubMed1989

Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate.

Patients with hemophilia A or von Willebrand's disease who are treated with concentrated preparations of human factor VIII made from unscreened pooled plasma are at substantial risk of contracting human immunodeficiency virus (HIV) infection. The purpose of this study was to investigate whether by treating such patients with a pasteurized factor VIII concentrate that had been heated in aqueous solution at 60 degrees C for 10 hours, HIV infection could be avoided. Eleven hemophilia centers in the Federal Republic of Germany and two in Austria identified 155 eligible patients who had been treated exclusively with pasteurized factor VIII concentrate and had not received any other blood products. Between February 1979 and December 1986 they received a total of 15,916,260 IU of pasteurized factor VIII. The United States was the source of 80 percent of the plasma from which the concentrate was made. By September 1988, these 155 patients had been screened for antibody to HIV type 1 (anti-HIV-1) with a total of 657 tests; all were negative. Sixty-seven patients were also tested once for antibody to HIV type 2 (anti-HIV-2); all these tests were negative as well. It appears that pasteurization effectively inactivates HIV, even in plasma that is likely to be highly contaminated with the virus.

Austria↗
PubMed1989

Growth and nutritional intake of infants with congenital heart disease.

Poor weight and length gain of infants with congenital heart disease is generally considered to be related to inadequate nutritional intake, but no longitudinal data on growth and nutritional intake of such infants are available. We compared weight, length, subscapular and triceps skinfold thickness, energy and protein intake (24-h dietary intake records) as well as serum prealbumin and albumin of infants with cyanotic heart disease (n = 8) or isolated left-to-right shunt (n = 8) with those of healthy infants aged (n = 8) 45-365 days. Weight, length, and combined (subscapular and triceps) skinfold thickness of the two groups with congenital heart disease (CHD) were significantly less from 183 through 365 days of age. However, energy and protein intake was similar to that of the control group from 45 through 365 days of age. Normal serum prealbumin and albumin in the infants with CHD ruled out protein-calorie malnutrition. It is concluded that a low level of food intake was not the main cause of inadequate growth and of small subcutaneous fat stores in these two small, but homogeneous, groups of infants with CHD.

Body Height↗
PubMed1988

[Preventive use of vitamin D and fluoride in Austria].

The implementation of the recommended daily vitamin D and fluoride supplements for infants in Austria has been investigated during a nationwide infant nutrition survey (n = 1069). 93.9% of the infants received daily vitamin D supplements, whereas only 38% received fluroide. Rejection of fluoride supplemtation was most common among mothers aged between 30 and 45 years and mothers with university education. In Carinthia, Vorarlberg and Styria only 2 out of 10 infants received fluoride supplements. It seems necessary to reconsider the recommendations for fluoride supplementation in Austria.

Adult↗
PubMed1988

Reliability of estimation of maximum performance capacity on the basis of submaximum ergometric stress tests in children 10-14 years old.

Thirty-three 10-year-old boys repeatedly performed six symptom-limited, spiroergometric exercise tests according to the vita maxima method over an observation period of 4 years. Submaximum and maximum performance parameters were assessed and their correlation was calculated. The correlation of the heart rate at 1, 2 and 3 watts/kg body weight with the values of maximum performance capacity (wattmax and VO2max) and with the body-weight-related, relative maximum values was statistically significant. The correlation factors for the relative values were about twice as high (r = 0.55) as the absolute values (r = 0.27). The heart rate at 1, 2 and 3 watts/kg therefore was more characteristic of the relative values, which represent the state of training, and less for the absolute performance capacity, which depends to a great extent on body weight. However, the statistically significant correlation factors were too low to estimate reliably the state of training in an individual case. The correlation of physical working capacity at an HR of 170/min (PWC 170) with the maximum ergometric Watt performance was r = 0.80 and therefore appears to be sufficient to estimate the maximum performance capacity in children. This is however only valid for children over the age of 11.

Body Weight↗
PubMed1988

Iron intake and iron nutritional status of infants fed iron-fortified beikost with meat.

We compared iron intake and iron nutritional status of two groups of healthy term infants who received meat-containing baby foods fortified with ferrous sulphate (2 mg Fe/100 g). One group received an Fe-fortified formula (1.6 mg Fe/100 kcal) and the other a nonfortified formula. Fe intake of the group fed the nonfortified formula was significantly lower (p less than 0.0001). These infants received Fe mainly from fortification Fe with beikost (75-86%) and less than 10% met the recommended intake of 1 mg.kg-1.d-1; whereas 80-85% of the infants fed the Fe-fortified formula did. Hb, Hct, FEP, and ferritin were similar in both groups with the exception of lower ferritin values at age 365 d (p less than 0.05) in the group fed the nonfortified formula. No infant had hemoglobin less than 100 g/L. We conclude that regular consumption of commercially prepared Fe-fortified beikost with meat prevents most healthy term infants from Fe deficiency even if Fe intake is substantially below the recommended intake.

Breast Feeding↗
PubMed1988

Obstructive sleep apnea: a polysomnographic study of sleep apnea before and after tonsillectomy and adenoidectomy.

We report about polysomnographic studies including EEG, EOG, EMG, ECG, measurement of oropharyngeal airflow, recording of chest wall movements and transcutaneous measurements of pO2 and pCO2 in a 4-year-old girl with severe obstructive sleep apnea. Her sleep profile was characterized by a disturbed cyclic pattern of sleep stages with onset of sleep at stage 4, shortening of REM-sleep periods and of sleep stages 1 and 2, and an increased quantity of sleep stage 4. The total time spent in apneic episodes was 11.3% of the total sleep period (only obstructive events). Apneic attacks were recorded mainly in REM and light NREM sleep states. Tonsillectomy and adenoidectomy resulted in marked improvement without further evidence of abnormal sleeping pattern or of sleep apneas.

Adenoidectomy↗
PubMed1987

Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates.

Recent data published on the prevalence of inhibitors to factor VIII in hemophiliacs on treatment show great variations, with prevalence rates ranging from 3.6 to 14.2%. We have studied the cumulative risk of inhibitor development in a cohort of 62 patients with hemophilia A. All patients were born after 1960, were natives of the Vienna area, had a factor VIII activity of less than 5%, and were treated at least once. Using the method of Cutler and Ederer, the cumulative risk of inhibitor development was found to be 24% at the age of 25 years. Most inhibitors developed between the ages of 3 and 7 years. The current prevalence of F VIII inhibitors in the group of patients studied is 17.5%. It is concluded that prevalence data underestimate the true risk of inhibitor development.

Adult↗
PubMed1986

[Lead intake from drinking water in the city of Vienna].

Daily lead intake from drinking water was estimated on the basis of lead concentrations in running and boiled drinking water samples of 42 Viennese households and reported drinking water consumption of adults living in those households. Lead concentration (means, SD, median) in running water samples (15.3 (37.9) micrograms Pb/l, median 6.3) was significantly higher (p less than 0.005) than in boiled water samples (6.4 (11.1) micrograms Pb/l, median 4.1). The highest lead concentrations in running water samples were found in houses built before 1945. Reported drinking water consumption was 1306 (576) ml/day (median 1242); more than 70% of drinking water was consumed at home. Calculated lead intake from drinking water in Vienna was 11.8 (22) micrograms Pb/day (median 5.2). Lead intake from drinking water was highest (19.5 (31.3) micrograms Pb/day, median 7.3) in houses built before 1945. Lead intake with food was calculated using published data on lead concentrations in food items and on food intake and data from the present study. Calculated average lead intake with food (206 micrograms Pb daily) was far below the estimated safe lead intake proposed by WHO 1972. We conclude that lead intake from drinking water in Vienna is low in most households. However, lead intake may be close to toxic levels if persons living in houses built before 1945 are consuming extremely large amounts of drinking water.

Adult↗
PubMed1985

Growth, zinc and copper nutritional status of male premature infants with different zinc intake.

Zinc is an essential nutrient for growth and low intake can result in growth retardation. However, high zinc intake can affect copper metabolism. Therefore, data from a study of 10 male premature infants fed a cow's milk-based formula nonfortified with zinc (mean +/- SD = 1.4 +/- 0.1 mg X l-1) were compared with data of 10 similar infants fed the same formula fortified with zinc (4.1 +/- 0.3 mg X l-1). Growth, food intake, zinc and copper nutritional status were studied from 6 through 122 days of age. No differences in gain of weight, length and head circumference and in food intake were found. Serum zinc concentration was significantly (p less than 0.05) and hair zinc concentration was slightly higher in the infants fed the zinc-fortified formula at 122 days of age. Copper and ceruloplasmin concentrations in serum and hair copper concentration were similar in both groups at 122 days of age. The results suggest that feeding a formula nonfortified with zinc did not affect growth of male premature infants. Feeding a zinc-fortified formula on the other hand had no influence on copper nutritional status.

Copper↗
PubMed1985

Lead content of water and of reconstituted infant formula in Vienna.

Daily lead intake from infant formula was estimated for young infants living in Vienna based on determinations of the lead concentration of drinking water and powdered formulas. The lead concentration in water was higher in houses built before 1945 (median 15.6 micrograms/l) than in houses built between 1945 and 1965 (median 4.4 micrograms/l) and in houses built after 1965 (median 2.8 micrograms/l). Boiling water for 1 min substantially reduced (p less than 0.0005) the lead concentration in water from all houses, apparently because of the coprecipitation of lead with boiler scale. The mean lead concentration in infant formula powder (n = 36) was 161.8 (SD 103.7) micrograms/kg. The lead concentration of an 'average' reconstituted infant formula, calculated using the mean lead concentration of boiled water (5.4 micrograms/l) and of formula powder, was 27.5 micrograms/l. This corresponded to 4.1 micrograms/100 kcal, which was substantially below the FDA maximum value of 16 micrograms/100 kcal. The lead concentration in the fat-free mass of a hypothetical young infant was estimated, assuming formula as the only source of lead and average values for caloric intake and retention of ingested lead. Between 0 and 4 months the estimated lead concentration in the fat-free mass declined from the concentration present at birth, indicating that the lead intake from formula is not likely to cause lead accumulation in the body during early infancy.

Austria↗
PubMed1984

Hemophilia and thrombocytopenia in a patient with impaired cellular immunity. A case report.

ITP in hemophiliacs may produce severe bleeding complications. We here report on an eight-year-old boy suffering from severe hemophilia A, who developed ITP and an acquired impaired immune function similar to AIDS. Steroid therapy reverted the thrombocyte count to normal, however it had to be discontinued because of a severe Cushing syndrome. The thrombocytopenia also responded to IgG-therapy and the patient is treated with a long term schedule according to Imbach. It is of interest that the impaired T-helper/T-suppressor cell ratio (0.45) improved to a value of 1.0 after initiation of this therapeutic regimen. We conclude from our observation that i.v. immunoglobulin therapy is of particular value for the treatment of ITP in patients with impaired cellular immunity.

Acquired Immunodeficiency Syndrome↗
PubMed1984

[Causes of phosphate deficiency syndromes and calcification disorders in premature infants fed human milk].

Premature infants fed human milk frequently show biochemical signs of phosphate depletion syndrome and bone undermineralisation. In order to explain those findings we calculated calcium- and phosphorus intake, -retention and -distribution in the body of premature infants and compared it to calcium- and phosphorus-gain and -distribution in the body of the fetus. The premature infants retained markedly less calcium and phosphorus than the fetus. Compared with the fetus premature infants utilized a higher percentage of retained phosphorus for formation of new body cell mass. Therefore, only a small amount of phosphorus was available for bone mineralisation. The calcium: phosphorus ratio in human milk is about 2:1 (mg:mg). Calcium is almost exclusively utilized for skeletal mineralisation and is deposited in bone in a 2,16:1 (mg:mg) ratio with phosphorus. Because of insufficient phosphorus supply for skeletal mineralisation, only part of the calcium provided with human milk could be utilized by the premature infants. In order to avoid disturbances of calcium-, phosphorus- and bone metabolism premature infants fed human milk need calcium and phosphorus supplementation.

Calcification, Physiologic↗